New hope for nasal polyp sufferers: long-term drug safety trial underway

NCT ID NCT06914908

Recruiting now Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 30 times

Summary

This study looks at the long-term safety and effectiveness of a drug called lunsekimig in adults with chronic sinusitis and nasal polyps that are not well controlled. Participants must have completed a previous lunsekimig study and will receive the drug for about 52 weeks, with a 4-week follow-up. The goal is to see if the drug remains safe and helps improve symptoms like nasal congestion and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alamo ENT Associates- Site Number : 8400001
RECRUITING

San Antonio, Texas, 78258, United States
ENT Associates of Texas - McKinne- Site Number : 8400014
RECRUITING

McKinney, Texas, 75070, United States
Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400008
RECRUITING

Norfolk, Virginia, 23510, United States
Essential Medical Research- Site Number : 8400020
RECRUITING

Tulsa, Oklahoma, 74137, United States
Investigational Site Number : 0320001
ACTIVE_NOT_RECRUITING

Buenos Aires, 1121, Argentina
Investigational Site Number : 0320002
ACTIVE_NOT_RECRUITING

Rosario, Santa Fe Province, 2000, Argentina
Investigational Site Number : 0320003
ACTIVE_NOT_RECRUITING

Mendoza, 5500, Argentina
Investigational Site Number : 0560001
ACTIVE_NOT_RECRUITING

Leuven, 3000, Belgium
Investigational Site Number : 0560002
ACTIVE_NOT_RECRUITING

Ghent, 9000, Belgium
Investigational Site Number : 1000001
RECRUITING

Sofia, 1612, Bulgaria
Investigational Site Number : 6160001
RECRUITING

Warsaw, Masovian Voivodeship, 00-909, Poland
Investigational Site Number : 6160002
RECRUITING

Krakow, Lesser Poland Voivodeship, 30-033, Poland
Investigational Site Number : 6160003
RECRUITING

Katowice, Silesian Voivodeship, 40-611, Poland
Investigational Site Number : 6160004
RECRUITING

Poznan, Greater Poland Voivodeship, 60-693, Poland
Investigational Site Number : 6160005
RECRUITING

Warsaw, Masovian Voivodeship, 02-507, Poland
Investigational Site Number : 6160007
RECRUITING

Wroclaw, Lower Silesian Voivodeship, 50-750, Poland
Investigational Site Number : 8260001
ACTIVE_NOT_RECRUITING

Newcastle upon Tyne, NE7 7DN, United Kingdom
Investigational Site Number : 8260003
ACTIVE_NOT_RECRUITING

Manchester, M13 9wl, United Kingdom
Investigational Site Number : 8260004
RECRUITING

Gloucester, Gloucestershire, GL1 3NN, United Kingdom
McGovern Medical School - UT Physicians Dermatology - Bellaire Station- Site Number : 8400017
RECRUITING

Bellaire, Texas, 77401, United States
Modena Allergy + Asthma- Site Number : 8400005
RECRUITING

La Jolla, California, 92037, United States
Pharmaceutical Research & Consulting- Site Number : 8400004
RECRUITING

Dallas, Texas, 75231, United States
Sacramento Ear Nose & Throat - Roseville- Site Number : 8400003
RECRUITING

Roseville, California, 95661, United States
Treasure Valley Medical Research- Site Number : 8400002
ACTIVE_NOT_RECRUITING

Boise, Idaho, 83706, United States

Conditions

Explore the condition pages connected to this study.

CHRONIC RHINOSINUSITIS WITH NASAL POLYPS